Journalist and news reader Peter Overton our new National Ambassador

Journalist and news reader Peter Overton our new National Ambassador

23 November 2021

Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.

Peter is a familiar face across Australia, spending the past 30 years as a journalist and news reader with the Nine Network. Having travelled the world to cover major world events including September 11 and the Bali bombings, and as a reporter with 60 minutes for nearly a decade, Peter is used to being on the news front line.

What Peter didn’t expect was to become the news - when he was first diagnosed with melanoma in November 2020. Peter underwent immediate surgery to remove the melanoma on his temple, which meant a stint in hospital and time away from the news desk. On his first night back on air, Peter selflessly shared his personal story, including his still healing surgical scars, as a warning to others to be sun safe and check their skin for changes.

Peter has since found three more melanomas on his back, requiring three more operations. Peter knows he is lucky as all his melanomas were caught early and removed before they had spread. With a high mole count, a childhood spent in the sun, and now with a history of melanoma, Peter is in a high risk group and undergoes regular screening and checks at Melanoma Institute Australia.

‘I am living proof that early detection saves lives, and as a proud dad to two teenage daughters, I am passionate about reaching young Australians with sun safety and early detection messages,’ Peter said. ‘I am delighted to be a National Ambassador for Melanoma Institute Australia which is focused on not only raising awareness, but which also leads global research efforts to find a cure for melanoma.’

‘We thank Peter for his generosity and passion in sharing his personal melanoma story to raise awareness about the disease, and also the importance of knowing your skin,’ said Melanoma Institute Australia CEO Matthew Browne. ‘Peter used his public profile to support our Game On Mole campaign in 2020 and 2021, and we are delighted to have him now join our organisation as National Ambassador. We look forward to working with Peter as we continue towards our mission of reaching zero deaths from melanoma.’

Watch the 9News segment where Peter discusses his melanoma experience and interviews MIA's Dr. Annika Smith: 

Peter joins Olympic swimming champion Cate Campbell as National Ambassador, and Ninja athlete Olivia Vivian, rugby great John Eales, personal trainer Shannan Ponton, and more recently our Game On Mole Ambassador Oceana Strachan, as valued MIA Ambassadors all impacted by melanoma who continued this year to generously donate their time to help us raise awareness and vital funds for research.

 

Kyly Clarke urges Aussies to step up to save lives from melanoma
03 Feb 2020

Kyly Clarke urges Aussies to step up to save lives from melanoma

Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.

Improving support for our patients across Australia.
03 Feb 2020

Improving support for our patients across Australia.

Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.   

Boost to melanoma support in WA
31 Jan 2020

Boost to melanoma support in WA

Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.

New Test to Predict Primary Melanoma Progression
21 Jan 2020

New Test to Predict Primary Melanoma Progression

Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.

Community Fundraising December Wrap-Up
14 Jan 2020

Community Fundraising December Wrap-Up

We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.

Two melanoma treatments approved for PBS listing
24 Dec 2019

Two melanoma treatments approved for PBS listing

Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.    

Immunotherapy: the decade's biggest health advance
23 Dec 2019

Immunotherapy: the decade's biggest health advance

An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.  

 

Boost to Melanoma Services in the Riverina
12 Dec 2019

Boost to Melanoma Services in the Riverina

Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.

Winner of the SunSafe Student Ambassador Program announced
11 Dec 2019

Winner of the SunSafe Student Ambassador Program announced

Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.

Community Fundraising November Wrap-Up
04 Dec 2019

Community Fundraising November Wrap-Up

It’s time again to say thank you to our amazing community fundraisers!

MIA & MPA Patient Information Evening videos now available
03 Dec 2019

MIA & MPA Patient Information Evening videos now available

Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.

MIA shines in poster session
22 Nov 2019

MIA shines in poster session

MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.

MIA Co-Medical Director opens SMR Congress in USA
21 Nov 2019

MIA Co-Medical Director opens SMR Congress in USA

Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.

Highly Cited Researchers List names MIA Co-Medical Directors
20 Nov 2019

Highly Cited Researchers List names MIA Co-Medical Directors

MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.

MPA and MIA collaboration
07 Nov 2019

MPA and MIA collaboration

Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.

Community Fundraising October Wrap-Up
04 Nov 2019

Community Fundraising October Wrap-Up

It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.

Promising data for advanced melanoma patients
09 Oct 2019

Promising data for advanced melanoma patients

MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.

Melanoma Information Forum
04 Oct 2019

Melanoma Information Forum

We are delighted to partner with Melanoma Patients Australia to host a Melanoma Information Forum at The Poche Centre on 6th November.

Community Fundraising September Wrap-Up
02 Oct 2019

Community Fundraising September Wrap-Up

Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.

Notice for Supporters to Submit to PBAC
26 Sep 2019

Notice for Supporters to Submit to PBAC

Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.